Update from the MRC London Institute of Medical Sciences (LMS)

Visualisation of new building. Image credit: Hawkins\Brown
Visualisation of new building. Image credit: Hawkins\Brown

New home for the LMS

In 2017 the Medical Research Council and Imperial College London announced a joint project to build a new home for the MRC London Institute of Medical Sciences (LMS) on the former Cyclotron site. The location of the LMS at the Hammersmith Hospital campus has supported the delivery of multidisciplinary research at the interface of medicine and basic science. The new building will bring the Institute together in a state-of-the-art collaborative research environment with specialist research facilities.

This month the project reached a major milestone with the submission of planning permission to the London Borough of Hammersmith and Fulham. The application will be live on the Council portal in a week’s time, with a planning decision expected in March 2019.

Alongside the development of the planning application, the procurement of the contractor for the project has begun. While the team await the planning decision the project has now moved into RIBA stage 4, the technical design stage. Our design team of Hawkins\BrownBuro Happold and Abell Nepp are continuing to work with the LMS and our project team to develop these plans over the coming months.

Further information and updates about the building development will be posted on the LMS website.

Peter Sarkies elected as EMBO Young Investigator

Congratulations to Dr Peter Sarkies who has been elected as a European Molecular Biology Organisation (EMBO) Young Investigator in recognition of his scientific excellence.

Peter heads the Transgenerational Epigenetic Inheritance & Evolution research group at the MRC LMS. He is one of 26 life science researchers selected as EMBO Young Investigators this year.

Peter’s group are interested in the relationship between epigenetics and evolution, looking into whether epigenetic changes can ever drive evolutionary changes, and how and for what reasons epigenetic mechanisms have evolved to be different in different species.

The EMBO Young Investigator Programme identifies recent group leaders with a proven record of scientific excellence and offers them access to a range of benefits during their four-year tenure.  He joins a network of 102 current and 314 past Young Investigators.

Further information on the LMS website.

Leave a Reply

Your email address will not be published. Required fields are marked *